Publication:
Comparison of Interim PET Response to Second-Line Versus First-Line Treatment in Classic Hodgkin Lymphoma: Contribution to the Development of Response Criteria for Relapsed or Progressive Disease.

No Thumbnail Available

Date

2020-08-06

Authors

Kluge, Regine
Wittig, Tim
Georgi, Thomas W
Kurch, Lars
Sabri, Osama
Wallace, W Hamish
Klekawka, Tomasz
Fernández-Teijeiro, Ana
Ceppi, Francesco
Karlén, Jonas

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

In first-line treatment of Hodgkin lymphoma (HL), Deauville scores 1-3 define complete metabolic remission. Interim 18F-FDG PET is also used for relapse-treatment adaptation; however, PET response criteria are not validated for relapse treatment. Methods: We performed a pairwise comparative analysis of early response to first- and second-line treatments in 127 patients with classic HL who experienced relapse. The patients participated in the prospective, multicenter EuroNet-PHL-C1 study. Residual uptake was measured retrospectively using the qPET method, a validated semiautomatic quantitative extension of the Deauville score. Empiric cumulative distribution functions of the qPET values were used to systematically analyze the response to first- and second-line treatments. Results: Individual patients responded variably to first- and second-line treatments. However, the empiric cumulative distribution functions of the qPET values from all patients were nearly superimposable. Conclusion: The findings support that first- and second-line treatments in HL do not require different response criteria.

Description

MeSH Terms

Adolescent
Child
Disease Progression
Female
Hodgkin Disease
Humans
Male
Positron-Emission Tomography
Recurrence
Treatment Outcome

DeCS Terms

CIE Terms

Keywords

Hodgkin lymphoma, PET response criteria, relapse

Citation